Percutaneous Transluminal Angioplasty Balloons Catheter Market
Global percutaneous transluminal angioplasty balloons catheters market is estimated to be valued at USD 1.82 Bn in 2024, and is expected to exhibit a CAGR of 9.1% during the forecast period (2024-2031). Percutaneous transluminal angioplasty (PTA) balloons catheters are used to widen arteries or veins that have been narrowed due to atherosclerosis or other conditions. PTA is a minimally invasive procedure that uses a balloon catheter to dilate stenosed or blocked blood vessels. The catheter is inserted into the femoral or brachial artery and threaded through to the site of narrowing under x-ray guidance. The balloon is then inflated, compressing plaque against the vessel walls to expand the artery. With repeated inflation-deflation cycles, the artery or vein is widened, improving blood flow. PTA balloons catheters have revolutionized the treatment of peripheral artery disease and coronary artery disease.
Market Dynamics
Global percutaneous transluminal angioplasty balloons catheters market growth is driven by rising geriatric population, increasing prevalence of cardiovascular diseases, and growing preference for minimally invasive procedures. Technological advancements in catheter design along with development of drug-coated balloons and bioabsorbable stents can drive the market growth. However, product recalls and failures can hamper the market growth. High cost of newer balloon catheter technologies can also hamper the market growth. The market witness opportunities in emerging markets due to improving access to healthcare. Key players are focusing on new product launches, collaborations and acquisitions to strengthen their product portfolios and geographic presence.
Key features of the study
- This report provides in-depth analysis of the global percutaneous transluminal angioplasty balloons catheters market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global percutaneous transluminal angioplasty balloons catheters market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Boston Scientific Corporation, Cardinal Health, BD, Medtronic, Terumo Medical Corporation, Cook Medical, Biotronik, AndraTec, Natec Medical, Shockwave Medical Inc., Abbott, Nipro Group Companies, Teleflex Incorporated, MicroPort Scientific Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global percutaneous transluminal angioplasty balloons catheters market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Market Segmentation
Table of Contents
*Browse 32 market data tables and 28 figures on 'Percutaneous Transluminal Angioplasty Balloons Catheter Market' - Global forecast to 2031
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
